| BLENDED MODE | 70% of lessons in presence 30% of lessons live streaming |
The Master in Clinical Research, Open Innovation & Market Access in the Digital Era is a journey into the world of medicine, starting from the initial idea, through its validation in preclinical and clinical trials, up to its launch on the market.
Participants will therefore acquire the fundamental knowledge to master the entire process (experimental, normative and regulatory) of a new drug for human health, essential knowledge to be protagonists in the professions of the sector.
A part of the Master is dedicated to medical devices, emerging and peculiar realities in the healthcare offering.
Recipients and access requirements
The Master is aimed in particular at:
- undergraduates* and recent graduates interested and motivated to embark on a path of professional growth in the pharmaceutical and biomedical sector;
- professionals with work experience, who intend to explore the most relevant and innovative issues in the sector.
Participants must be in possession of a Bachelor's degree of the old system, or a Specialist or a Master's degree. Those who do not possess the required qualification will be able to attend the Master as auditors.
Enrollment in the Master is compatible with enrollment in another university course in accordance with the provisions of Law no. 33 of 12/04/2022 and by DM 930 of 29/07/2022.
*provided the degree title is obtained within 90 days of the start date of the Master.
Didactic structure and thematic areas
The Master is structured in 6 thematic areas:
- The context: ethics, competitiveness, pre-clinical path
- Management and conduct of a study
- Regulatory, legal and insurance aspects
- Role of technological and social health innovation
- Trials of medical devices: reference contexts
- Authorization procedures and market access
The BLENDED and PART-TIME FORMULA makes the Master compatible and contextual with professional commitments and responsibilities. The teaching structure will be divided into 70% of in-person lessons and 30% of live stream lessonsing.
In order to facilitate the acquisition of the contents covered during the Master's modules, at the end of each lesson there will be a specific Q&A session dedicated to the review of the topics covered with the aim of rereading them through a common thread. This approach intends to support participants in consolidating the contents of the Master, verify the effective acquisition of the concepts covered and evaluate any need for additional in-depth study.
Participation fee, concessions and scholarships
The participation fee for the Master is € 5.000,00 with the possibility of paying in installments.
All payments, including that relating to the application for admission, must be made to a bank current account, the references are given below:
Accountholder - Università Campus Bio-Medico di Roma
Bank - UNICREDIT SPA
IBAN: IT63Y0200805181000106877148
Specify the reason for each payment (Name and Surname - Master in Clinical Research).
Discounted fees are available for undergraduates and graduates of theUniversità Campus Bio-Medico di Roma, UCBM Academy Ambassador, staff of the Campus Bio-Medico University Hospital Foundation.
There is the possibility of accessing fully covered scholarships.
Method of admission
The application for admission to the Master must be submitted by 16 January 2025 using the online procedure which requires the insertion of:
- personal data
- curriculum vitae
- Ofchiarasubstitutive certification
- payment of the admission fee € 60,00
The motivational interviews will take place on 22 January 2025.
Title awarded
II level University Master in Clinical Research, open innovation and market access in the digital age with the award of 60 university credits (CFU).